Search database
Filter
138
Featured
Language
Document type
75
40
8
8
4
2
1
Countries
6
6
5
4
4
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
28
14
9
9
4
4
4
3
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
44
32
7
4
3
2
2
Toolboxes
33
10
10
9
6
4
4
2
2
2
1
1
1
1
1
1
WPSAR Vol 8, No 4, 2017 | doi: 10.5365/wpsar.2017.8.3.005 DOI: http://dx.doi.org/10.5365/wpsar.v8i4.564

Universal Periodic Review of Albania - 33rd Session

Albania Center for Population and Development (ACPD); Albanian Association of People Living with HIVAIS; Roma Active Albania; STOP AIDS; Aksion Plus; et al. (2019) C2
Joint Stakeholder Submission Accessed: 29.09.2019
16.7.2021
(Last Update: July 2022)
WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials ... more
WHO’s Essential Medicines List and List of Essential Diagnostics are core guidance documents that help countries prioritize critical health products that should be widely available and affordable throughout health systems. The updated Essential Medicines List adds 23 medicines for children.
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination ... more

Hepatology. A Clinical Textbook

Stefan Mauss, et al. Flying Publisher, Boehringer Ingelheim (2015)

Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS)

Communicable Disease Control Branch - Manitoba Health (2010) C2
Communicable Disease Control Branch Communicable Disease Management Protocol – Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS), February 2010
The strategy focuses on mobilizing and coordinating partners, experts and resources to help countries enhance surveillance of the Zika virus and disorders that could be linked to it, improve vector control, effectively communicate risks, guidance and protection measures, provide medical care to thos ... more
Clinical care for severe acute respiratory infection: toolkit: COVID-19 adaptation